Guardant Health Overview
Guardant Health Target Price
Analysts' 12-month price predictions for GH.
Share Price
$48.41
Average Target Price
$52.00
7.4% upside
7.4% upside1 analysts in the last 4 months
High: $52 | Low: $52
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-05 | Morgan Stanley | $52 | 7.4% upside |  |
| 2024-08-21 | UBSDan Leonard | $40 |  17.4% downside | |
| 2024-08-08 | Craig-HallumBill Bonello | $37 | 23.6% downside | |
| 2024-08-08 | JefferiesTycho Peterson | $40 | 17.4% downside | |
| 2024-07-29 | BTIGMark Massaro | $50 | 3.3% upside | |
| 2024-06-28 | GuggenheimSubbu Nambi | $36 | 25.6% downside | |
| 2024-06-04 | Canaccord GenuityKyle Mikson | $38 | 21.5% downside | |
| 2024-06-03 | JefferiesTycho Peterson | $32 | 33.9% downside | |
| 2024-05-23 | BTIGMark Massaro | $45 | 7% downside | |
| 2024-05-22 | Canaccord GenuityKyle Mikson | $30 | 38% downside | |
| 2024-04-24 | Craig-HallumChase Knickerbocker | $28 | 42.2% downside | |
| 2023-09-27 | Piper SandlerDavid Westenberg | $40 | 17.4% downside | |
| 2023-02-06 | Goldman Sachs | $45 | 7% downside | |
| 2022-12-16 | Morgan StanleyTejas Savant | $80 | 65.3% upside | |
| 2022-12-16 | Canaccord GenuityKyle Mikson | $65 | 34.3% upside | |
| 2022-10-05 | StephensMason Carrico | $99 | 104.5% upside | |
| 2022-08-08 | Goldman Sachs | $80 | 65.3% upside | |
| 2022-05-09 | J.P. MorganJulia Qin | $125 | 158.2% upside | |
| 2021-06-03 | Goldman SachsMatthew Sykes | $160 | 230.5% upside | |